Global trends and academic landscapes of ultrasound applications in lung cancer research: a bibliometric analysis (2000–2024) Authors: Qiang Huang, Wenmei Su, Shujun Li, Yongcun Wang, Yanming Lin, Zhen Cheng, Yanli Mo Published: 2025 ABSTRACT AbstractObjectiveThis study aims to systematically evaluate the global distribution, academic impact, and technological trends of ultrasound technology in lung cancer research from 2000 to 2024 through bibliometric analysis, providing references for future research directions.Materials and methodsBased on the Web of Science Core Collection database, 2,617 publications from 2000 to 2024 were included. Bibliometric analysis was conducted using VOSviewer and CiteSpace, covering publication trends, countries, institutions, authors, journals, highly cited literature, and keyword co-occurrence networks. Metrics such as publication volume, citation count, and total link strength (TLS) were quantitatively assessed.ResultsFrom 2000 to 2024, the annual number of publications on ultrasound in lung cancer diagnosis and treatment surged from 19 to 218, with the last five years accounting for 38% of the total, indicating a continuous increase in research activity. The United States (554 publications) and China (387 publications) contributed 48% of the global output. The U.S. led in total citations (24,413), while Germany demonstrated superior research quality with an average of 57 citations per publication. Chiba University (Japan, 48 publications), the National Cancer Center Japan, and Shanghai Jiao Tong University School of Medicine (each with 46 publications) were the most productive institutions. The international collaboration network formed a multi-center cluster with the U.S. as the core. Japanese scholar Kazuhiro Yasufuku (56 publications/3,320 citations) had the highest influence, and highly cited authors generally relied on strong international collaborations (TLS ≥ 76). Chest (86 publications/10,664 citations) was the most influential core journal in the field. Citation analysis revealed that endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) technology and lung cancer staging guidelines (highest cited: 225 times) were key research focuses. Keyword clustering identified four major research directions: bronchoscopic diagnosis, minimally invasive biopsy, comprehensive treatment, and imaging staging. Burst detection highlighted emerging hotspots such as “safety” (strength = 15.13), “yield” (17.91), “peripheral pulmonary lesions” (12.98), and “radial endobronchial ultrasound” (12.72), indicating a shift from traditional diagnosis toward efficiency quantification, precision navigation (e.g., radial ultrasound), and intelligent analysis.ConclusionFrom 2000 to 2024, the academic influence of ultrasound in lung cancer research significantly increased, with research hotspots evolving from technical standardization to precise staging and multimodal applications. The integration of AI and multimodal technology represents a core future direction. Introduction Lung cancer remains the leading cause of cancer-related deaths worldwide, with approximately 2.2 million new cases and 1.8 million deaths annually [1]. Despite advances in diagnostic and therapeutic approaches, significant challenges remain in early detection, accurate staging, and personalized treatment. Conventional imaging techniques such as computed tomography (CT) and positron emission tomography (PET) are limited in real-time guidance and functional assessment. Ultrasound (US) is a non-invasive, cost-effective, and dynamic imaging tool that has become increasingly important in the diagnosis and management of lung cancer. Recent developments in multimodal techniques, including contrast-enhanced ultrasound (CEUS), elastography, and interventional ultrasound, have broadened its applications. Ultrasound plays a key role in lung cancer diagnosis and staging. CEUS improves tumor microvascular imaging, aiding in screening and early diagnosis. Radial endobronchial ultrasound (R-EBUS) offers a diagnostic yield of up to 73% for peripheral lung lesions [2]. Robotic bronchoscopy combined with electromagnetic navigation improves biopsy accuracy, with success rates reaching 80% [3, 4]. Qing DY et al. [5] showed that CEUS helps differentiate pathological types of peripheral lung cancer: non-small cell lung cancer (NSCLC) often displays centripetal enhancement (72.7%)​, while small cell lung cancer (SCLC) commonly exhibits eccentric enhancement (92.9%). CEUS also shows potential in distinguishing adenocarcinoma from squamous cell carcinoma. Ultrasound-guided methods, including EBUS-TBNA and endoscopic ultrasound-guided fine needle aspiration (EUS-B-FNA), enhance detection of mediastinal lymph node metastases. These techniques are particularly useful in high-risk patients with negative PET or CT results, enabling identification of occult metastases and improving staging and treatment [6, 7]. Due to its strengths in dynamic imaging and minimally invasive intervention, ultrasound ​has become essential for addressing the shortcomings of conventional imaging in lung cancer. However, the rapidly expanding research in this area necessitates a bibliometric analysis to quantify multimodal innovation trends, evaluate collaboration networks, and anticipate new directions such as AI integration. Bibliometrics can uncover knowledge connections and detect emerging keywords, helping to identify key contributors, forecast advances, and support evidence-based decisions and interdisciplinary collaboration. Materials and methods Data source and search strategy The Web of Science Core Collection (WoSCC) was selected as the primary database for this study, incorporating the Science Citation Index Expanded and Emerging Sources Citation Index. These databases cover multidisciplinary literature and are widely used in bibliometric research. The retrieval was conducted on 2 February 2025 to ensure data consistency and minimize the impact of daily database updates. The search strategy used the following query: (TS=(“ultrasound”) OR TS=(“contrast-enhanced ultrasound”) OR TS=(“CEUS”) OR TS=(“ultrasound elastography”) OR TS=(“interventional ultrasound”) OR TS=(“ultrasomics”) OR TS=(“microbubbles”) OR TS=(“acoustic radiation force imaging”) OR TS=(“ultrasound-guided”)) AND (TS=(“lung cancer”) OR TS=(“non-small cell lung cancer”) OR TS=(“NSCLC”) OR TS=(“small cell lung cancer”) OR TS=(“SCLC”) OR TS=(“lung tumor”) OR TS=(“lung nodule”) OR TS=(“pulmonary lesion”)). A total of 4,008 English articles published between January 2000 and December 2024 were retrieved. The collected data included titles, authors, affiliations, abstracts, keywords, publication dates, journal names, references, and citation counts. Articles were filtered to include only those in English (3,873 records) and of the type “Article” (2,841 records), resulting in 2,738 publications. After manual screening, 121 articles unrelated to lung cancer or ultrasound technology were excluded. The final dataset comprised 2,617 articles. Any discrepancies during screening were resolved through team discussion. For further analysis, data were saved in two formats: (1) plain text files (.txt) with full records and cited references for CiteSpace; and (2) tab-separated files for VOSviewer. Bibliometric analysis VOSviewer (version 1.6.20) was used to analyze co-occurrence networks of countries, institutions, authors, and keywords. In the visualizations, node size represents frequency of occurrence or co-occurrence, and connecting lines indicate the strength of relationships between entities. Total Link Strength (TLS) was applied to evaluate the overall connectivity among nodes, helping reveal knowledge structures, collaboration patterns, and research hotspots. Higher TLS values indicate more active and extensive connections, often pointing to core nodes in the network. CiteSpace (version 6.3.R1 Basic) was employed to visualize collaboration networks and analyze evolving research trends, including keyword burst detection. The analysis focused on the most productive countries, institutions, and authors, along with the most-cited articles and journals. Keyword trend analysis was also performed to identify emerging research focuses and shifts over time. Results Annual publication trend analysis This study included 2,617 publications on the application of ultrasound in lung cancer diagnosis and treatment, contributed by 10,970 authors from 2,539 research institutions across 68 countries/regions. These works were published in 597 journals and cited 35,480 references. From 2000 to 2024, the annual number of publications increased from 19 to 218, with an average annual growth of 8.3 papers. The cumulative publication count grew by 137 times, as shown in Fig. 1. Notably, 994 papers (38%) were published in the last five years, indicating rapidly growing research interest in this field. The number of pubticaticins and cite tons from 21:11:10 to 2024 Country analysis A total of 2,617 articles from 68 countries were analyzed. As shown in Fig. 2A, the United States (554 papers) and China (387 papers) dominated in total output, together accounting for 48% of global publications. Japan (249), Germany (158), and Italy (125) ranked third to fifth, respectively. The U.S. led in total citations (24,413), while Germany demonstrated high research quality with an average of 57 citations per paper. The global collaboration network (Fig. 2B) revealed that the U.S. occupies a central hub position, maintaining extensive partnerships with countries such as China, the UK, Italy, and Canada. China, Japan, and Germany also showed active international collaboration, though with slightly lower connectivity and breadth compared to the U.S. Analysis of countries and institutions. A. The top 10 countries by academic ouput: publications, citations & citations/documents. The top 10 countries with the highest number of publications. B. collaboration network between countries. C. The number of publications and citations in the top 10 institutions Institution analysis A total of 2,538 institutions worldwide were identified. In terms of output (Fig. 2C), Chiba University (Japan) led with 48 publications, followed by the National Cancer Center Japan and Shanghai Jiao Tong University School of Medicine, both with 46 papers. Notably, three institutions each from the U.S. and Japan ranked among the top ten. The collaboration network among high-yield institutions (≥ 12 publications per year, Fig. 2D) comprised 57 nodes forming 8 clusters. The largest cluster (red) included 19 institutions, centered around MD Anderson Cancer Center, Johns Hopkins University, and the Medical University of South Carolina. The second-largest cluster (green) consisted of 9 institutions, including Heidelberg University and the University of Amsterdam. Author analysis A total of 10,970 authors were included. Table 1 lists the top 10 most prolific authors. Kazuhiro Yasufuku (Japan) led with 56 publications and 3,320 total citations, demonstrating outstanding academic output and influence. He was followed by Takahiro Nakajima (Japan, 43 papers/2,425 citations) and Jouke T. Annema (Netherlands, 34 papers/1,908 citations). Felix J. F. Herth (Germany) ranked fourth with 25 publications but achieved a notably high average of 66.8 citations per paper, reflecting significant research quality. Table 1The top 10 productive authors and the top 10 co-cited authorsRankAuthorDocumentsCitationsTLSCitations/DocumentsCited-authorsCitationsTLS1Yasufuku, Kazuhiro56332012659.29Yasufuku, Kazuhiro93395302Nakajima, Takahiro43242511356.40Herth, Felix J. F.77494043Annema, Jouke T3419084956.12Silvestri, GA58861544Herth, Felix J. F.2516714166.84Annema, JT50979335Sun, Jiayuan25476619.04Nakajima, T46840496Tsuchida, Takaaki254626218.48Steinfort, DP42138037Matsumoto, Yuji254305817.20Oki, M39841208Zarogoulidis, Paul244055216.88Detterbeck, FC35740819Yoshino, Ichiro2211647652.91Vilmann, P348508810Steinfort, Daniel P228363238.00Wallace, MB3244867TLS: Total Link Strength The top 10 productive authors and the top 10 co-cited authors TLS: Total Link Strength Among all 29,016 cited authors, 64 received 90 or more citations, indicating considerable influence within the field. Yasufuku (TLS = 9,530) and Herth (TLS = 9,404) ranked first and second in citation impact, with high TLS scores suggesting broad integration of their work across research contexts. Yasufuku, Nakajima, and Herth appeared in both the high-output and high-citation top-10 lists, marking them as the most active and influential core scholars. Highly cited authors also exhibited strong collaborative networks, e.g., Yasufuku (TLS = 126), Nakajima (TLS = 113), and Ichiro Yoshino (TLS = 76), each with average citations exceeding 50 per paper, underscoring the positive correlation between international collaboration and academic impact. In contrast, Chinese scholar Jiayuan Sun (fifth in output) had a TLS of only 6, reflecting a high-output but low-collaboration pattern, suggesting a primarily independent research team with limited international engagement. The sustained productivity of Yasufuku and Nakajima may stem from systematic research approaches, warranting further study of their organizational models. Temporal network analysis can be used to trace evolving research themes and international collaboration dynamics among core authors. Journal analysis Academic journals play an essential role in disseminating scientific knowledge and promoting the sharing and translation of research outcomes. The distribution of publications is highly concentrated: among the 597 journals included, the top 10 journals published 527 articles, accounting for 20.1% of the total literature (Table 2). Notably, 70% of these top journals belong to the JCR Q1 category. Table 2The top 10 journals and the top 10 cited-journalsRankJournalDocumentsCitationsTLSJCRJournalCitationsTLSJCR1Chest8610,6641783Q1Chest6433152,198Q12Journal of Thoracic Disease75780472Q3The Annals of Thoracic Surgery231868,961Q13Respiration721928632Q1Journal of Thoracic Oncology185049,087Q14Annals of Thoracic Surgery663280730Q1European Respiratory Journal149240,074Q15Lung Cancer521995602Q1Gastrointestinal Endoscopy127440,749Q16Thoracic Cancer44342252Q2Thorax126438,257Q17Journal of Thoracic Oncology392258562Q1Lung Cancer122937,844Q18European Respiratory Journal322229589Q1Radiology117838,325Q19Respirology321227296Q1The Journal of Thoracic and Cardiovascular Surgery113136,338Q110Bmc Pulmonary Medicine29606192Q2American Journal of Respiratory and Critical Care Medicine112432,918Q1 The top 10 journals and the top 10 cited-journals Chest led with 86 publications, 10,664 citations, and a TLS of 1,783. Although Annals of Thoracic Surgery ranked fourth in output (66 articles), it placed second in citations (3,280), reflecting the strong quality of leading journals. Thoracic Cancer, despite ranking sixth in annual publication volume, had relatively low total citations, suggesting room for improvement in the academic impact of some of its articles. It is noteworthy that all top 10 highly cited journals are classified as JCR Q1. As shown in Fig. 3, the journal co-citation network generated using VOSviewer illustrates the intellectual structure of the field through node size (influence), color clusters (thematic focus), and link strength (relatedness). The green cluster, centered around Chest, focuses on chronic airway diseases, interstitial lung disease, and the integration of ultrasound in lung cancer diagnosis and treatment. The yellow cluster, represented by Annals of Thoracic Surgery, highlights advances in surgical treatment and multidisciplinary management of thoracic oncology. The red cluster, typified by Journal of Thoracic Disease, emphasizes imaging diagnosis and radiotherapy technologies. The blue cluster, anchored by Gastrointestinal Endoscopy, specializes in image-guided interventional diagnosis and therapy. With the largest node size, Chest serves as a key interdisciplinary platform, integrating ultrasound technology with standards in lung cancer care. The top 10 cited journals Citation analysis From an initial pool of 35,480 cited references, 67 core publications were identified using a citation threshold of ≥ 50. Table 3 lists the top 10 most-cited articles, which exhibit a clear thematic focus on two major areas: ultrasound-guided puncture techniques and lung cancer staging guidelines. This reflects the ongoing consensus-building and standardization of key technologies in the field. Table 3The top 10 most-cited publicationsRankTitleCitationsTLSTime1Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines225107120132Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes180114320043Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis177118020094Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum160118320065Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)159121320076Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer154112720057A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer14288320118Mediastinoscopy vs. endosonography for mediastinal nodal staging of lung cancer: a randomized trial13998420109Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer131985200610Regional lymph node classification for lung cancer staging1237511997TLS: Total Link Strength The top 10 most-cited publications TLS: Total Link Strength 70% (7/10) of the highly cited articles focus on EBUS-TBNA. The most-cited technical publication (180 citations) systematically evaluated its diagnostic performance in mediastinal staging of lung cancer. Subsequent meta-analyses and prospective controlled trials (142–154 citations) further confirmed its role as a replacement for conventional mediastinoscopy. The most-cited article overall (225 citations) was the 3rd edition of the “Guidelines for Staging Lung Cancer” by the American College of Chest Physicians (ACCP). Another guideline (159 citations) established ultrasound as a standard in invasive staging, underscoring the lasting impact of clinical guidelines. Early studies (e.g., 1997) primarily explored EBUS applications in radiologically normal lymph nodes. Later publications shifted toward comparative technical studies, such as prospective trials (2010) and randomized trials (2011), indicating an evolution from initial exploration to routine clinical adoption. Keyword analysis A keyword co-occurrence network was constructed using VOSviewer. Synonyms were merged, and a threshold of “at least 50 occurrences per keyword” was applied. From 2,617 articles, 6,517 keywords were extracted, and 68 core nodes were ultimately selected. A visualization map of keyword co-occurrence was generated. Figure 4A displays the keyword co-occurrence heatmap. Using VOSviewer, the top 68 keywords were clustered into four groups (Fig. 4B). The thematic clustering identified four major research focuses: bronchoscopic diagnostic techniques, minimally invasive biopsy and lymph node assessment, comprehensive treatment strategies, and imaging and precise staging. Cluster 1 (green) focused on “bronchoscopic diagnostic techniques and clinical applications in lung cancer,” including keywords such as lung cancer, endobronchial ultrasound, biopsy, and bronchoscopy. Cluster 2 (yellow) centered on “minimally invasive biopsy techniques and lymph node pathological assessment,” featuring diagnosis, EBUS-TBNA, EBUS, and feature. The frequent co-occurrence of cytology and on-site evaluation reflects the critical role of rapid pathological diagnosis in clinical decision-making. The presence of utility and experience indicates that research in this field not only focuses on the techniques themselves but also emphasizes the optimization and summarization of clinical applications. Cluster 3 (red) revolved around “treatment strategies and clinical management,” including ultrasound, chemotherapy, radiotherapy, surgery, and management. Cluster 4 (blue) primarily addressed “imaging diagnosis and precise staging techniques for lung cancer,” with keywords such as CT, FDG-PET, positron emission tomography, endoscopic ultrasound, staging, and accuracy. The analysis of keywords in the study. A. Keyword co-occurrence hotspot map visualization. B. Clustering of keywords. C. Keyword burst analysis results from 2000 to 2024 A temporal analysis of keyword burst strength (Fig. 4C) revealed the dynamic evolution of research hotspots in lung cancer. In the early stage (2000–2011), traditional diagnostic techniques such as fine-needle aspiration (burst strength: 26.16) and CT imaging (26.04) laid the research foundation. A key shift occurred in 2019, with a concentrated emergence of diagnostic efficiency indicators (yield: 17.91; diagnostic yield: 15.35), marking a transition toward quantitative evaluation of diagnostic efficacy. The ongoing prominence of radial endobronchial ultrasound (sustained burst during 2022–2024) indicates that navigation techniques for peripheral lung cancer represent a current frontier. Future research should focus on balancing and optimizing diagnostic efficiency and safety. Discussion This bibliometric analysis reveals a consistent growth in research on ultrasound applications in lung cancer from 2000 to 2024. The technological evolution has progressed from standardization toward precision and intelligence. Research focus has expanded beyond traditional diagnostic validation toward multimodal integration. Accurate diagnosis and staging of lung cancer are central to clinical decision-making, directly influencing treatment strategies and patient outcomes. While non-invasive imaging techniques such as CT and PET are widely used for mediastinal staging, their limited specificity necessitates histopathological confirmation. Among invasive procedures, EBUS-TBNA offers diagnostic accuracy comparable to mediastinoscopy—the historical gold standard—with improved safety and lower cost. The strong co-occurrence of keywords like EBUS-TBNA, biopsy, and diagnosis underscores its pivotal role in mediastinal lymph node assessment. The 2013 ACCP guidelines established ultrasound-guided biopsy as the preferred method for mediastinal staging, citing sensitivities of 89–91%, significantly superior to CT (55%) and PET (77%) [8]. This recommendation reflects both the demand for TNM staging accuracy and the establishment of a new standard for subsequent technical innovations. Advances in targeted therapy and immunotherapy have improved survival in non-small cell lung cancer (NSCLC), heightening the clinical value of obtaining adequate cytological samples via EBUS-TBNA for molecular testing. A study by Faber et al. from Johns Hopkins University involving 865 EBUS-TBNA samples demonstrated that using 22G needles alongside multi-omics analysis increased biomarker detection rates to 87% [9]. Their findings support that small thoracic specimens can effectively provide prognostic and predictive biomarker information recommended by current NSCLC guidelines. Re-evaluating mediastinal lymph nodes is crucial for optimizing individualized treatment strategies. In patients with mediastinal nodal involvement, neoadjuvant chemotherapy may be considered. EBUS-TBNA allows repeated sampling of lymph nodes, enabling restaging after neoadjuvant therapy and informing subsequent therapeutic decisions. The emergence of keywords such as “diagnostic yield” and “yield” reflects a research focus on improving diagnostic efficiency, while “safety” underscores the emphasis on optimizing procedural security. The transformation toward AI-driven diagnostic paradigms has emerged as a new frontier. AI-based imaging analysis models have demonstrated clinical value: the Xception architecture achieved an AUC of 0.93 in predicting mediastinal lymph node metastasis [10], and the DFA-UNet model, integrating ConvNext and visual transformer technologies, improved the segmentation accuracy of ultrasound elastography to 96.7% [11]. These advances highlight AI’s core strength in enhancing the standardization and automation of lung cancer ultrasound diagnosis through improved feature extraction. Multicenter validation studies further reinforce the reliability of these technologies. For example, the HAL/HOMER model, developed in a prospective multicenter study led by MD Anderson (Martinez-Zayas et al.) [12], demonstrated the auxiliary decision-making value of EBUS-TBNA in 1,799 NSCLC patients. Chinese researchers are leading in multimodal intelligent diagnostics, with a radiomics model achieving an AUC of 0.894 for predicting lymph node metastasis [13]. In the diagnosis and treatment of peripheral lung cancer, the integration of multimodal navigation systems has shown significant clinical value. Chinese scholar Sun Jiayuan developed an ultrathin bronchoscopy multimodal navigation system that achieved a diagnostic rate of 81% [14]. Japanese teams led by Matsumoto (TLS = 317) and Imabayashi (TLS = 278) improved the diagnostic rate for peripheral lung lesions (e.g., GGN) from 77.6% to 89.2% by introducing cryobiopsy and proposed that obtaining ≥ 4 tissue samples optimizes NGS performance (sensitivity 73.8%, specificity 61.5%) [15, 16]. A multicenter randomized trial further confirmed that combining EBUS-TBNA with mediastinal cryobiopsy increased the diagnostic rate for mediastinal lesions from 81% to 93% (p = 0.0039), with comparable safety [17]. The NAVIGATE study also indicated that electromagnetic navigation bronchoscopy (ENB) combined with R-EBUS achieved a 12-month diagnostic rate of 73% for peripheral lung lesions (median diameter 20.0 mm), with only 2.9% serious adverse events [18]. The rapid navigation (median 5 min) and high tissue acquisition rate (94%) of ENB [18] demonstrate the deep integration of ultrasound with electromagnetic positioning and real-time imaging. Ultrasound-guided thermal ablation techniques, such as microwave and radiofrequency ablation, have become effective minimally invasive alternatives for inoperable lung cancer patients. In pulmonary radiofrequency ablation (RFA), the use of radial endobronchial ultrasound-guided catheters enables precise tumor localization. Combined with neuromuscular blockade to prevent complications, this approach enhances procedural safety [19]. An international collaborative study led by Herth, Felix J.F., from Heidelberg University, Germany, further validated a navigational bronchoscopy microwave ablation system [20]. It achieved a 78.6% complete ablation rate and a 71.4% 2-year local control rate in peripheral lung cancer, significantly advancing precision minimally invasive therapy. Leveraging real-time dynamic imaging, ultrasound-guided techniques allow accurate identification of metastatic lymph node features—such as cortical thickening and loss of hilar structure—enabling dynamic adjustment of lymph node dissection during surgery and significantly improving staging accuracy [21]. Intraoperative contrast-enhanced ultrasound (Io-CEUS) achieved 100% localization accuracy for pulmonary nodules ≤ 4.5 cm. Hemodynamic analysis via Io-CEUS facilitates preoperative prediction of histological characteristics, guiding precise resection strategies [22]. In perioperative management, ultrasound-guided paravertebral block significantly reduced postoperative opioid consumption (sufentanil, P < 0.001) and incidence of nausea (P < 0.05) compared with retrolaminar block [23]. In targeted therapy, ultrasound-targeted microbubble destruction (UTMD) has revealed molecular mechanisms for reversing drug resistance in lung cancer [24, 25]. Additionally, sonodynamic therapy combined with nanocarriers has demonstrated potential for targeted tumor treatment in animal models [26]. The integration of ultrasound with targeted nano-contrast agents is expected to further expand personalized therapeutic applications in lung cancer. Limitations This study has several limitations. The data were sourced exclusively from the Web of Science Core Collection (WoSCC), which may have resulted in the omission of key literature from Scopus or PubMed. The focus on English publications might also exclude cutting-edge research published in other languages. Furthermore, the 2000–2024 time frame did not fully capture early technological developments. Despite these constraints, this analysis provides a systematic empirical foundation for understanding the technological evolution of ultrasound applications in lung cancer. Conclusion This study reveals a rapid increase in research on ultrasound for lung cancer diagnosis and treatment, with publications in the past five years accounting for 38% of the total output. The United States and China contributed the most publications, while Germany led in research quality. International collaboration was centered around the United States, with Japanese and American institutions being the most productive. Research focus has shifted from early puncture biopsy techniques to diagnostic efficiency evaluation, with current frontiers focusing on radial ultrasound-guided navigation technology for peripheral lung lesions. Scholars such as Yasufuku, K. constitute the core research force in the field. Future efforts should strengthen cross-regional collaboration and optimize clinical translation. Acknowledgements We sincerely thank Guangdong Medical University for its invaluable support of this research. We also acknowledge Quiltbot (http://quillbot.com) for its assistance in grammar review. Author contributions QH: Writing – original draft, Software, Visualization. WS: Writing – review & editing. SL: Data curation. YW: Software. YL: Visualization. ZC: Data curation, Software. YM: Data curation, Formal analysis, Methodology, Project administration, Software, Supervision, Visualization, Writing – original draft. Funding Special Project for Clinical and Basic Sci & Tech Innovation of Guangdong Medical University. Data availability No datasets were generated or analysed during the current study. Declarations Ethics statement and consent to participate Ethical approval for this study was waived by the Ethics Committee of the Affiliated Hospital of Guangdong Medical University because the research involved only bibliometric analysis of publicly available literature data. No direct human participation or personal information was utilized. Written informed consent was also waived in accordance with institutional guidelines. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.